Through the 90-day period concluding January 14, 2026, Oncology Institute's top three insider stakeholders include Director Growth I L.P. M33 (5.44Mn shares), Director Richard A Barasch (4.57Mn shares), Director Ravi Yang Sarin (4.19Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Growth I L.P. M33 | 5,444,207 | 20 Nov, 2025 | |
| Richard A Barasch | 4,571,022 | 20 Jun, 2025 | |
| Ravi Yang Sarin | 4,185,198 | 21 Mar, 2023 | |
| Daniel Virnich | Chief Executive Officer | 1,799,984 | 19 Nov, 2025 |
| Brad Hively | 683,721 | 16 Dec, 2025 | |
| Mark L Pacala | 481,732 | 24 Nov, 2025 | |
| Mihir Shah | Chief Financial Officer | 474,931 | 23 May, 2024 |
| Gabriel Ling | 333,539 | 24 Nov, 2025 | |
| Anne Mcgeorge | 291,370 | 24 Nov, 2025 | |
| Karen Marie Johnson | 288,286 | 24 Nov, 2025 | |
| Mohit Kaushal | 268,302 | 24 Nov, 2025 | |
| Richy Agajanian | 253,436 | 13 May, 2022 | |
| Healthcare Partners, L.P. Havencrest | 252,626 | 20 Aug, 2024 | |
| Jeremy Castle | Chief Operating Officer | 247,031 | 22 May, 2025 |
| Matthew P Miller | Chief Operating Officer | 242,992 | 21 Mar, 2023 |
| Yale Podnos | Chief Medical Officer | 237,930 | 19 Nov, 2025 |
| Robert Ross Carter | Chief Financial Officer | 235,125 | 06 Jan, 2026 |
| Scott Dalgleish | Chief Financial Officer | 151,008 | 23 Mar, 2022 |
| Maeve O'Meara | 109,104 | 28 Dec, 2023 | |
| Kristin England | Chief Administrative Officer | 98,037 | 24 Jul, 2025 |
| James E Flynn | 85,113 | 16 Nov, 2021 | |
| Jeffrey Langsam | Chief Clinical Officer | 57,380 | 23 May, 2025 |
| Diona Simoneit | Chief Accounting Officer | 39,705 | 21 Nov, 2022 |
| Sponsor Llc Dfp | 40 | 16 Nov, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Jan, 2026 | Robert Ross Carter | Common Stock | D | 247 | $3.56 | 235,122 | D | S |
| 02 Jan, 2026 | Robert Ross Carter | Common Stock | D | 244 | $3.67 | 235,125 | D | J |
| 15 Dec, 2025 | Brad Hively | - | - | 683,721 | D | |||
| 15 Dec, 2025 | Brad Hively | Common Stock | D | 13,333 | $3.77 | 683,721 | D | S |
| 20 Nov, 2025 | Mark L Pacala | Common Stock | A | 46,296 | $0.00 | 221,267 | D | A |
| 20 Nov, 2025 | Mark L Pacala | Common Stock | A | 35,494 | $0.00 | 256,761 | D | A |
| 20 Nov, 2025 | Mohit Kaushal | Common Stock | A | 40,123 | $0.00 | 268,302 | D | A |
| 20 Nov, 2025 | Mohit Kaushal | Common Stock | A | 50,926 | $0.00 | 228,179 | D | A |
| 20 Nov, 2025 | Anne Mcgeorge | Common Stock | A | 40,123 | $0.00 | 291,370 | D | A |
| 20 Nov, 2025 | Anne Mcgeorge | Common Stock | A | 67,901 | $0.00 | 251,247 | D | A |
| 20 Nov, 2025 | Brad Hively | Common Stock | A | 32,407 | $0.00 | 697,054 | D | A |
| 20 Nov, 2025 | Brad Hively | Common Stock | A | 41,667 | $0.00 | 664,647 | D | A |
| 20 Nov, 2025 | Karen Marie Johnson | Common Stock | A | 37,037 | $0.00 | 288,286 | D | A |
| 20 Nov, 2025 | Karen Marie Johnson | - | - | 251,249 | D | |||
| 20 Nov, 2025 | Karen Marie Johnson | Common Stock | A | 47,840 | $0.00 | 251,249 | D | A |
| 20 Nov, 2025 | Gabriel Ling | Common Stock | A | 37,037 | $0.00 | 333,539 | D | A |
| 20 Nov, 2025 | Gabriel Ling | Common Stock | A | 46,296 | $0.00 | 296,502 | D | A |
| 20 Nov, 2025 | Gabriel Ling | - | - | 333,539 | D | |||
| 18 Nov, 2025 | Mark L Pacala | Common Stock | D | 46,630 | $4.00 | 174,971 | D | S |
| 18 Nov, 2025 | Mark L Pacala | Common Stock | D | 1,210 | $4.00 | 221,601 | D | S |